AVIR vs CRM · $353.7M cap vs P/E 41, rev $11.35B
Atea Pharmaceuticals Inc (AVIR) versus Salesforce.com Inc (CRM) — a side-by-side from cached financials, not a winner call.
Atea Pharmaceuticals Inc (AVIR) is a biotechnology company listed on US.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc R. Benioff.
AVIR does not have a complete income-statement cache yet.
Latest reported CRM revenue for 2026-07-31 was $11.35B. Net income was $3.53B. Revenue was up 1.9% from 2026-04-30 to 2026-07-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
AVIR currently screens at market cap $353.7M. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
Not investment advice. Open the AVIR and CRM stock pages for the full models.
Not investment advice.